Increasing Access to Breast Cancer Screening Among Immigrants
NCT ID: NCT04672265
Last Updated: 2024-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
11355 participants
INTERVENTIONAL
2021-04-15
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Under- and Overdiagnosis in BreastScreen Norway
NCT03852953
Increasing Breast Cancer Screening in Chinese Immigrants
NCT05089292
Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria
NCT07080515
Testing Video Information About Mammography Screening
NCT04424758
Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening
NCT05731453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mother tongue and Norwegian
Written material related to screening sent to the invitee in two languages.
Mother tongue and Norwegian
The screening invitation letter, the information leaflet, the reminder letter and the result letter will be sent in two languages; an official language in the country where the invitee is born, and Norwegian.
Norwegian
Written material related to screening sent to the invitee in Norwegian only.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mother tongue and Norwegian
The screening invitation letter, the information leaflet, the reminder letter and the result letter will be sent in two languages; an official language in the country where the invitee is born, and Norwegian.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The registered country of birth of the invitee is one of the following; Poland, Pakistan, Philippines, Somalia, Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia
Exclusion Criteria
48 Years
73 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paula Berstad
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paula Berstad, PhD
Role: PRINCIPAL_INVESTIGATOR
Norwegian Institute of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital, Cancer Registry
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hofvind S, Iqbal N, Thy JE, Mangerud G, Bhargava S, Zackrisson S, Berstad P. Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway. BMJ. 2023 Sep 19;382:e075465. doi: 10.1136/bmj-2023-075465.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
213396
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
19/218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.